Biodelivery Sciences International reported $72.47M in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acelrx Pharmaceuticals ACRX:US $ 6.95M 2.42M
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Agile Therapeutics AGRX:US $ 16.43M 0.4M
Cti Biopharma CTIC:US $ 0M 0M
Daiichi Sankyo 4568:JP Y 143254M 20093M
Depomed DEPO:US $ 66.41M 0.34M
Endo International Ordinary Shares ENDP:US $ 8070.77M 3.67M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Knight Therapeutics Inc GUD:CN C$ 2.72M 176K
Lannett LCI:US $ 596.98M 6.29M
Mannkind MNKD:US $ 280.73M 0.47M
Nektar Therapeutics NKTR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 326.15M 4.44M
Redhill Biopharma RDHL:US $ 86.36M 0.23M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Teva Pharmaceutical TEVA:IT 21.04B 565M